Sunovion Pharmaceuticals Inc. Donates Laboratory Equipment to Massachusetts General Hospital to Aid in Research of Neurological Disorders
Marlborough, Mass., April 15, 2014 – Sunovion Pharmaceuticals Inc. (Sunovion) today announced the donation of laboratory equipment to the Massachusetts General Hospital (MGH) MassGeneral Institute for Neurodegenerative Disease (MIND), the hospital’s integrative research center for neurodegenerative diseases. MGH-MIND encompasses more than 30 laboratories devoted to the study of prevention, treatment and cures for neurological disorders such as Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis (ALS) and Huntington’s disease, and is the scientific home of the Massachusetts Alzheimer’s Disease Research Center (ADRC), where the donated equipment will primarily be used. The Massachusetts ADRC explores the causes of Alzheimer’s disease and the underlying mechanisms of the illness to gain greater understanding of how new therapies can be developed.
Sunovion is also a member of the Massachusetts Life Sciences Center (MLSC) Neuroscience Consortium, which facilitates industry-academic collaborations in neurobiology and neuroscience. The first round of MLSC grants funded the laboratory of Dr. Bradley T. Hyman in the ADRC, and Sunovion learned of the need for research equipment during the discussions on how to accelerate his research and others at the MIND Institute.
“The gift of equipment from Sunovion to the laboratory and MGH-MIND will support further studies of the biochemical changes that occur in Alzheimer’s disease,” said Dr. Brad Hyman, M.D., Ph.D., Director of the Massachusetts ADRC in Charlestown, Mass. “We are thankful that Sunovion reached out to us when they learned we were in need of equipment to aid in this critical research.”
Additionally, the equipment will broadly aid studies of how the brain works across all the neurological diseases studied at MGH-MINDS. The donation includes tools from the neuropharmacology research and behavioral pharmacology research laboratories at Sunovion, which focus on discovering new drugs principally for neuropsychiatric diseases.
"Sunovion is committed to the research and development of treatments to help patients with neuropsychiatric and neurological illnesses, and this is an opportunity for our Company to have an even further reach to these patients,” said Tom Large, Senior Vice President of Discovery Research at Sunovion. “While we continue our own research operating through a global network of academic, biotech and contract research partners, we saw a need and hope this donation to MGH-MINDS can help their research and ultimately, improve health care delivery for those living with neurological disease.”
"We established the Massachusetts Neuroscience Consortium to promote collaboration among global industry leaders in CNS for the purpose of accelerating early-stage neuroscience research," said Susan Windham-Bannister, Ph.D., President & CEO, Massachusetts Life Sciences Center. "This donation is an excellent example of how collaboration drives innovation and supports the discovery of promising treatments. Thank you Sunovion for your generosity and spirit of partnership!"
About Sunovion Pharmaceuticals Inc. (Sunovion)
Sunovion is a leading pharmaceutical company dedicated to discovering, developing and commercializing therapeutic products that advance the science of medicine in the Psychiatry & Neurology and Respiratory disease areas and improve the lives of patients and their families. Sunovion’s drug development program, together with its corporate development and licensing efforts, has yielded a portfolio of pharmaceutical products including Aptiom® (eslicarbazepine acetate) tablets, Latuda® (lurasidone HCl) tablets, Lunesta® (eszopiclone) tablets, Xopenex® (levalbuterol HCI) inhalation solution, Xopenex HFA® (levalbuterol tartrate) inhalation aerosol, Brovana® (arformoterol tartrate) inhalation solution, Omnaris® (ciclesonide) nasal spray, Zetonna® (ciclesonide) nasal aerosol and Alvesco® (ciclesonide) inhalation aerosol.
Sunovion, an indirect, wholly-owned U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd., is headquartered in Marlborough, Mass. More information about Sunovion Pharmaceuticals Inc. is available at www.sunovion.com.
About the Massachusetts Life Sciences Center (MLSC)
The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a 10-year, $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation's most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences. For more information, visit www.masslifesciences.com.
©2014 Sunovion Pharmaceuticals Inc. All rights reserved.
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.